<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03596996</url>
  </required_header>
  <id_info>
    <org_study_id>1608M92324</org_study_id>
    <nct_id>NCT03596996</nct_id>
  </id_info>
  <brief_title>Optimizing Iron Status While Minimizing Morbidity in HIV-infected Ugandan Children</brief_title>
  <official_title>Optimizing Iron Status While Minimizing Morbidity in HIV-infected Ugandan Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Joint Clinical Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Minnesota</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized, placebo-controlled trial of the effect of 84 days of daily iron supplementation
      on iron status, gut microbiome profile, infectious disease frequency, and HIV disease
      severity in moderately anemic [hemoglobin 9 - &lt;11 g/dL (6-59 mo); hemoglobin 9 - &lt; 11.5 g/dL
      (5 -12 years)], HIV-infected Ugandan children between the ages of 6 mos and 12 years.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 19, 2018</start_date>
  <completion_date type="Anticipated">April 19, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 19, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hemoglobin</measure>
    <time_frame>3 months</time_frame>
    <description>Measurement of hemoglobin</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anemia</measure>
    <time_frame>3 months</time_frame>
    <description>Prevalence of anemia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Iron status</measure>
    <time_frame>3 months</time_frame>
    <description>Iron status measured using ferritin, sTfR, CRP and hepcidin concentration in plasma</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sick Child Visits</measure>
    <time_frame>3 months</time_frame>
    <description>Number of acute illnesses leading to visit to healthcare provider</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary iron absorption</measure>
    <time_frame>2 weeks</time_frame>
    <description>Percentage of 57Fe from oral dose that is incorporated into hemoglobin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HIV virologic control</measure>
    <time_frame>3 month</time_frame>
    <description>HIV viral load</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HIV related immunosuppression</measure>
    <time_frame>3 months</time_frame>
    <description>CD4 count</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Microbiome gut profile</measure>
    <time_frame>3 months</time_frame>
    <description>Ratio of Enterobacteriaceae to Lactobacillaceae and Bifidobacteriaceae</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Anemia</condition>
  <condition>Iron-deficiency</condition>
  <condition>Iron Deficiency Anemia</condition>
  <condition>Hiv</condition>
  <arm_group>
    <arm_group_label>Ferrous Sulfate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children 6 to 23 months of age will receive a tablet that contains the equivalent of 12.5 mg of elemental iron. Children over 24 months will receive a tablet that contains the equivalent of 30 mg of elemental iron.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ferrous Sulfate</intervention_name>
    <description>Ferrous sulfate dosed by WHO guidelines by age for the prevention of iron deficiency and anemia.</description>
    <arm_group_label>Ferrous Sulfate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo with identical appearance comparison intervention arm</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Confirmed diagnosis of HIV (based JCRC clinic records);

          2. On Highly Active Antiretroviral Treatment (HAART) for ≥ 6 months

          3. Age 6 months - 12 years at the time of screening

          4. Hemoglobin 9 - &lt;11 g/dL (6-59 mo); hemoglobin 9 - &lt; 11.5 g/dL (5 -12 years)by CBC at
             time of screening

        Exclusion Criteria:

          1. Acute illness or current opportunistic infection

          2. Temperature &gt;= 38.0°C at the time of screening

          3. Known sickle cell disease

          4. Acute malnutrition (bilateral pitting edema or extreme wasting)

          5. Any chronic illness requiring regular medical attention

          6. Residence &gt; 50 km from JCRC hospital

          7. Non-English or Luganda speaking

          8. Currently taking iron supplements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Cusick, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne E Frosch, MD</last_name>
    <phone>612 626 1980</phone>
    <email>park0587@umn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sarah Cusick, PhD</last_name>
    <phone>612 626 1980</phone>
    <email>scusick@umn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Joint Clinical Research Centre</name>
      <address>
        <city>Kampala</city>
        <country>Uganda</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victor Musiime</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Uganda</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 5, 2018</study_first_submitted>
  <study_first_submitted_qc>July 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2018</study_first_posted>
  <last_update_submitted>July 15, 2019</last_update_submitted>
  <last_update_submitted_qc>July 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

